Impaired Cholesterol Efflux Capacity May Help Explain Development of Early Coronary Artery Disease in Subjects with Very High HDL-C

Simple item page
dc.contributor.otherRodrigues, Amrithen
dc.contributor.otherTrinidade, Kevinen
dc.contributor.otherRisman, Marjorieen
dc.contributor.otherQu, Limingen
dc.contributor.otherCuchel, Marinaen
dc.contributor.otherBillheimer, Jeffreyen
dc.contributor.otherRader, Daniel J.en
dc.creatorAgarwala, Ananditaen
dc.date.accessioned2015-07-08T12:00:50Z
dc.date.available2015-07-08T12:00:50Z
dc.date.issued2014-02-04
dc.descriptionThe 52nd Annual Medical Student Research Forum at UT Southwestern Medical Center (Tuesday, February 4, 2014, 3-6 p.m., D1.502)en
dc.description.abstractPlasma levels of high-density lipoprotein cholesterol (HDL-C) are strongly inversely associated with coronary artery disease (CAD), and high HDL-C is generally associated with apparent 'protection' from CAD. A minority of individuals with very high HDL-C levels also develops CAD, a paradoxical phenotype. We hypothesize that such individuals may have HDL with altered structure and/ or function, and compared these individuals (cases) to individuals with very high HDL-C without CAD (controls). We identified 55 subjects with HDL-C above the 90th percentile, early CAD, and no major risk factors for coronary disease. We selected 120 controls without CAD, each matched for race, gender, and HDL-C level. Controls were selected to be the same age or no more than 10 years older than the cases. Studies to assess HDL composition and size distribution, cholesterol efflux capacity, and lecithin-cholesterol acyltransferase (LCAT) activity in cases and controls were conducted. Comparison of HDL particle characteristics between cases and controls demonstrated a significant reduction in HDL phospholipid composition between cases and controls (92 ± 37 mg/dl vs. 109 ± 43 mg/dL, p value 0.0095). The mean plasma total cholesterol efflux capacity was significantly reduced in subjects with elevated HDL-C and CAD as compared to controls (1.96 ± 0.39 % efflux/ 2hr/ 1% plasma vs. 2.11 ± 0.43 % efflux/ 2hr/ 1% plasma, p value 0.040). The reduction became even more significant when looking at mean ABCA1- selective cholesterol efflux between cases and controls 0.60 ± 0.24 % efflux/ 2hr/ 1% plasma vs. 0.71 ± 0.32 % efflux/ 2hr/ 1% plasma, p value 0.033). Furthermore, there was a significant reduction in mean efflux per HDL particle in cases as compared to controls (0.023 ± 0.005 % efflux/ 2hr/ 1% plasma vs. 0.025 ± 0.006 % efflux/ 2hr/ 1% plasma, p value 0.029). No significant difference was observed between cases and controls in HDL particle size or plasma LCAT activity. Reduced cholesterol efflux capacity in cases with elevated HDL-C and CAD may explain the development of early coronary artery disease. This finding reinforces the belief that cholesterol efflux capacity may in fact be a better predictor of the risk of coronary disease then HDL-C levels alone. Furthermore, the reduction in HDL phospholipid in the cases may help account for impaired cholesterol efflux.en
dc.description.sponsorshipSouthwestern Medical Foundationen
dc.identifier.citationAgarwala, A., Rodrigues, A., Trinidade, K., Risman, M., Qu, L., Cuchel, M., . . . Rader, D. J. (2014, February 4). Impaired cholesterol efflux capacity may help explain development of early coronary artery disease in subjects with very high HDL-C. Poster session presented at the 52nd Annual Medical Student Research Forum, Dallas, TX. Retrieved from //hdl.handle.net/2152.5/1653en
dc.identifier.urihttps://hdl.handle.net/2152.5/1653
dc.language.isoenen
dc.relation.ispartofseries52nd Annual Medical Student Research Forumen
dc.subjectClinical Research and Case Reportsen
dc.subject.meshCholesterolen
dc.subject.meshCholesterol, HDLen
dc.subject.meshCoronary Artery Diseaseen
dc.subject.meshLipoproteins, HDLen
dc.titleImpaired Cholesterol Efflux Capacity May Help Explain Development of Early Coronary Artery Disease in Subjects with Very High HDL-Cen
dc.typePresentationen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Agarwala MSRF DDCRF poster 2014.pdf
Size:
234.49 KB
Format:
Adobe Portable Document Format
Description:
PDF--public access
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
297 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Annual Medical Student Research Forum